Oculis Holding AG (OCS)
NASDAQ: OCS · Real-Time Price · USD
17.60
-0.98 (-5.27%)
At close: May 12, 2025, 4:00 PM
18.20
+0.60 (3.41%)
After-hours: May 12, 2025, 5:23 PM EDT

Oculis Holding AG Income Statement

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
0.750.690.880.910.960.99
Revenue Growth (YoY)
-14.50%-22.31%-3.18%-5.00%-3.32%-
Cost of Revenue
52.0852.0829.2522.229.579.34
Gross Profit
-51.33-51.4-28.36-21.31-8.61-8.34
Selling, General & Admin
22.621.8117.4911.064.623.99
Operating Expenses
26.5221.8117.4911.064.623.99
Operating Income
-77.85-73.2-45.85-32.38-13.23-12.34
Interest Expense
-0.85-0.64-1.32-6.44-5.12-2.63
Interest & Investment Income
2.172.171.430.130.020.01
Currency Exchange Gain (Loss)
-2.091.27-4.660.05-0.190.16
Other Non Operating Income (Expenses)
-24.46-15.53-3.43--00
EBT Excluding Unusual Items
-103.08-85.94-53.83-38.64-18.53-14.79
Merger & Restructuring Charges
---34.86---
Pretax Income
-103.08-85.94-88.7-38.64-18.53-14.79
Income Tax Expense
-0.18-0.160.110.060.030.08
Net Income
-102.9-85.78-88.8-38.7-18.55-14.87
Net Income to Common
-102.9-85.78-88.8-38.7-18.55-14.87
Shares Outstanding (Basic)
434030333
Shares Outstanding (Diluted)
434030333
Shares Change (YoY)
20.82%35.14%774.89%7.63%23.11%-
EPS (Basic)
-2.38-2.12-2.97-11.32-5.84-5.77
EPS (Diluted)
-2.38-2.12-2.97-11.32-5.84-5.77
Free Cash Flow
--47.73-53.89-25.14-13.85-12.05
Free Cash Flow Per Share
--1.18-1.80-7.36-4.36-4.67
Operating Margin
-10393.86%-10671.14%-5192.64%-3550.00%-1378.33%-1242.30%
Profit Margin
-13737.92%-12503.94%-10056.85%-4243.20%-1932.50%-1497.78%
Free Cash Flow Margin
--6957.58%-6103.40%-2756.47%-1443.02%-1213.29%
EBITDA
-77.37-72.8-45.56-32.08-13.14-12.23
D&A For EBITDA
0.480.410.290.30.090.1
EBIT
-77.85-73.2-45.85-32.38-13.23-12.34
Revenue as Reported
0.690.690.880.910.960.99
Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q